Stockholders’ Deficit and Stock-Based Compensation - Schedule of Options Activity (Details) - 2022 Omnibus Plan - Options to purchase common stock - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2025	Dec. 31, 2024
Shares
Balances at the beginning (in shares)	335,883
Granted (in shares)	277,575
Exercised (in shares)	0
Forfeited (in shares)	(2,834)
Balances at the ending (in shares)	610,624	335,883
Weighted Average Exercise Price
Balances at the beginning (in dollars per share)	$ 2.49
Granted (in dollars per share)	1.38
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	1.55
Balances at the ending (in dollars per share)	$ 1.99	$ 2.49
Weighted Average Contractual Life (in years)
Balances at the ending (in years)	8 years 6 months 21 days	7 years 9 months 10 days
Granted (in years)	9 years 9 months 25 days
Aggregate Intrinsic Value (in thousands)
Outstanding at beginning of period	$ 0
Granted	0
Exercised	0
Forfeited	0
Outstanding at end of period	$ 0	$ 0
Vested and exercisable at period end (in shares)	212,102
Vested and exercisable at period end (in dollars per share)	$ 2.50
Vested and exercisable at period end (in years)	7 years 6 months 3 days
Vested and exercisable at end of period (intrinsic value)	$ 0